A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies.
There has been great interest in genetic risk prediction using risk scores in recent years, however, the utility of scores developed in European populations and later applied to non-European populations has not been successful. The goal of this study was to create a methylation risk score (MRS) for...
Guardado en:
Autores principales: | Bertha A Hidalgo, Bre Minniefield, Amit Patki, Rikki Tanner, Minoo Bagheri, Hemant K Tiwari, Donna K Arnett, Marguerite Ryan Irvin |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/497a6248df3448a8a7ae3bc451ee5293 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
A 6-CpG validated methylation risk score model for metabolic syndrome: The HyperGEN and GOLDN studies
por: Bertha A. Hidalgo, et al.
Publicado: (2021) -
AGT M235T genotype/anxiety interaction and gender in the HyperGEN study.
por: Sarah S Knox, et al.
Publicado: (2010) -
Low biological fluctuation of mitochondrial CpG and non-CpG methylation at the single-molecule level
por: Chloe Goldsmith, et al.
Publicado: (2021) -
CpG-Based Nanovaccines for Cancer Immunotherapy
por: Chen W, et al.
Publicado: (2021) -
Genomics of Postprandial Lipidomics in the Genetics of Lipid-Lowering Drugs and Diet Network Study
por: Marguerite R. Irvin, et al.
Publicado: (2021)